Purpose <p>Eye cancer is a rare but life-threatening condition resulting from uncontrolled proliferation of cells within the ocular region. The intraocular cancers have been diagnosed by conventional diagnostic techniques, with ultimate limitations of invasiveness and inability to discriminate malignant from benign lesions. Delayed diagnosis, lack of targeting, and variability in the treatment approaches continue to affect the outcomes and quality of life among ocular cancer patients. A comprehensive understanding of existing literature is essential for improving early detection, effective management and guiding future research directions. This review aims to provide updated overview of advances in diagnostics, therapeutics and emerging research directions in eye cancer research.</p> Methods <p>This is a narrative review that provides conceptual insights into ocular cancer, including its pathogenesis, diagnostic approaches, management strategies, and future perspectives. Relevant literature was identified scientific databases and publisher platforms, including Elsevier, Springer, Taylor &amp; Francis, MDPI, Frontiers, Wiley and other relevant sources, using keywords such as “ocular cancers,” “Intraocular cancers” “eye cancer pathophysiology,” “diagnosis of eye cancer,” and “management and treatment of eye cancer.” Articles were selected based on their relevance to the topic, scientific quality, and contribution to the understanding of ocular oncology. The selected articles were carefully studied and included in qualitative synthesis.</p> Results <p>The study identified a broad range of diagnostic innovations, therapeutic strategies, and ongoing investigational therapies. Imaging advancements, Gene profiling and biomarkers have improved early detection and tumor characterization. Treatment varied with tumor types, including enucleation, radiation therapy, laser therapy and systemic and intravitreal chemotherapies being commonly practiced. Emerging treatments including immunotherapy, gene-based therapy, Nanotechnology, biologics and anti-angiogenic drugs showed promising preliminary results.</p> Conclusion <p>Current literature demonstrated substantial progress in the diagnostic and therapeutic strategies with a comprehensive understanding of pathophysiological events in eye cancer. The future research should focus on strengthening early detection, long term outcome evaluation, integration of emerging targeted and immunotherapeutic modalities, to further improve patient survival and ocular preservation.</p>